Skip to main content
logo
Rani Therapeutics Holdings, Inc. (RANI)
NASDAQ: RANI · Real-Time Price · USD
0.8510
-0.0656 (-7.16%)
At close: Aug 20, 2026, 4:00 PM EDT
0.8600
+0.0090 (1.06%)
After-hours: Aug 20, 2026, 7:16 PM EDT

RANI Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
1191324686146322
Market Cap Growth
347.20%188.57%-46.89%-41.09%-54.75%-
Enterprise Value
691415273107273
Last Close Price
0.851.351.373.325.9016.35

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
24.3280.6544.39--118.62
PB Ratio
2.443.1713.073.381.972.65
P/TBV Ratio
3.023.9922.916.683.966.80

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
14.1086.3450.21--100.44

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.070.108.511.180.41-
Net Debt / Equity Ratio
-1.04-1.090.59-0.72-0.92-0.97
Net Debt / EBITDA Ratio
1.551.21-0.040.281.092.30
Net Debt / FCF Ratio
2.452.41-0.060.351.423.59
Asset Turnover
0.130.030.02--0.03
Quick Ratio
5.234.091.416.1020.4544.49
Current Ratio
5.314.211.506.3720.9645.30
Return on Equity (ROE)
-172.15%-181.98%-391.10%-136.52%-64.78%-54.94%
Return on Assets (ROA)
-53.00%-50.27%-65.57%-49.79%-34.15%-31.68%
Return on Capital Employed (ROCE)
-65.60%-83.40%-296.20%-132.40%-61.50%-42.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-25.41%-22.53%-65.78%-39.54%-20.97%-2.58%
FCF Yield
-17.15%-14.28%-78.37%-61.06%-33.00%-10.16%
Buyback Yield / Dilution
-321.63%-132.26%-11.65%-7.09%-21.93%58.34%
SEC Filings: 10-K · 10-Q